Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2007-03-19

Clinical Trial Update: TBTC Study 27: Moxifloxacin vs Ethambutol for TB Treatment [Phase 2]

View source ↗

Summary

A Phase 2 trial comparing moxifloxacin to ethambutol for treatment of pulmonary tuberculosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ethambutol (ethambutol)
  • Moxifloxacin (moxifloxacin)

Snippet

Sponsor: Centers for Disease Control and Prevention | Conditions: Tuberculosis, Pulmonary | Phase 2 | Status: COMPLETED